autoimmune disease

Search with Google Search with Bing
Information
Disease name
autoimmune disease
Disease ID
DOID:417
Description
"An immune system disease that is an overactive immune response of the body against substances and tissues normally present in the body resulting from an abnormal functioning of the immune system that results in the production of antibodies or T cell directed against the host tissues." [url:http\://en.wikipedia.org/wiki/Autoimmune_disease] {comment="ls:IEDB"}
Disease area statistics
[No Data.]
Chromosome band
[No Data.]
Annotation
NCT ID Status Phase Summary Start date Completion date
NCT00716066 Active, not recruiting Phase 2 Autologous Stem Cell Transplant for Neurologic Autoimmune Diseases June 2008 January 31, 2030
NCT00001630 Completed Phase 1 Treatment of Autoimmune Thrombocytopenia (AITP) July 21, 1997 June 11, 2009
NCT00001658 Completed Phase 4 Amoxicillin for the Treatment of Pediatric Autoimmune Disorders Associated With Streptococcal Infections July 1997 June 2001
NCT00013689 Completed Phase 1 Pyrimethamine and Sulfadoxine for Treatment of Autoimmune Lymphoproliferative Syndrome March 2001 March 2003
NCT00065390 Completed Phase 1 Pyrimethamine to Treat Autoimmune Lymphoproliferative Syndrome July 2003 June 2005
NCT00114530 Completed Phase 2/Phase 3 Scleroderma: Cyclophosphamide or Transplantation June 2005 April 2016
NCT00340600 Completed Continuation of Follow-up of DES-Exposed Cohorts March 18, 1998 November 13, 2020
NCT00341198 Completed Confirmation of Systemic Autoimmune Diseases in the Agricultural Health Study April 2, 2002 December 12, 2006
NCT00351377 Completed Phase 3 Gastrointestinal and Health-related Quality of Life Outcomes in Patients With Autoimmune Diseases Treated With Mycophenolate June 2006 June 2009
NCT00372177 Completed Phase 1/Phase 2 The Use of Anti-CD4 Monoclonal Antibody (mAb)-Fragment for the Imaging of Chronic Inflammation in Patients With Active Rheumatoid Arthritis July 2007 May 2008
NCT00001306 Completed Steroid Therapy in Autoimmune Premature Ovarian Failure July 10, 1992 December 12, 2011
NCT00968084 Completed Screening Protocol for Subjects Being Evaluated for Center for Human Immunology, Autoimmunity, and Inflammatory Diseases (CHI) Protocols August 6, 2009 October 25, 2017
NCT01086631 Completed Phase 1 Rituximab for Autoimmune Retinopathy January 22, 2010 July 8, 2014
NCT01196091 Completed Phase 3 A Study of LY2127399 in Participants With Systemic Lupus Erythematosus December 2010 June 2015
NCT01205438 Completed Phase 3 A Study of LY2127399 in Participants With Systemic Lupus Erythematosus January 2011 March 2015
NCT01281969 Completed Phase 3 Intravenous Immunoglobulin for PANDAS January 2011 August 13, 2018
NCT01773031 Completed Pancreatic Duct Evaluation in Autoimmune Pancreatitis: MR Pancreatography January 2013 March 2015
NCT01815996 Completed Identify Clinical Conditions That Increase Circulating DNA Levels October 2012 July 28, 2016
NCT02219256 Completed Phase 1 A Phase 1 Study to Assess the Safety, Tolerability, and Pharmacokinetics of TAK-079 in Healthy Participants August 2014 April 2016
NCT02263703 Completed Phase 3 Immunogenicity of HPV Vaccine in Immunosuppressed Children May 2007 December 2016
NCT02434458 Completed Sudoscan in Patients With Autoimmune Disorders May 2015 September 2015
NCT02647866 Completed Phase 2 Study of a Monoclonal Antibody KHK4083 in Moderate Ulcerative Colitis June 2016 October 2018
NCT02925351 Completed Early Phase 1 Fluorine F 18 Clofarabine PET/CT in Imaging Patients With Autoimmune or Inflammatory Diseases January 25, 2016 April 30, 2018
NCT05894707 Not yet recruiting Phase 1 Evaluate the Safety and Tolerability of SCT650C in Healthy Volunteers June 2023 March 2024
NCT06004349 Recruiting Autoimmune and Autoinflammatory Genetics Study April 15, 2022 April 5, 2032
NCT00943514 Recruiting Natural History of Bronchiectasis August 1, 2009
NCT03816345 Recruiting Phase 1 Nivolumab in Treating Patients With Autoimmune Disorders and Advanced, Metastatic, or Unresectable Cancer July 16, 2019 August 31, 2024
NCT00977977 Recruiting Phase 2 Rituximab Plus Cyclosporine in Idiopathic Membranous Nephropathy December 22, 2010 January 31, 2025
NCT04751396 Recruiting Testing of an Educational Tool for Patients With Melanoma and Pre-Existing Autoimmune Disease Who Are Candidates for Immune Checkpoint Inhibitors April 20, 2022 April 15, 2025
NCT01280825 Recruiting The 1200 Patients Project: Studying the Implementation of Clinical Pharmacogenomic Testing January 14, 2011 December 14, 2027
NCT03186794 Terminated N/A Aerobic Exercise in Women With Systemic Lupus Erythematosus February 22, 2018 February 25, 2021
NCT01488708 Terminated Phase 3 On Open-Label Study in Participants With Systemic Lupus Erythematosus January 2012 October 2015
NCT03715699 Unknown status N/A Leflunomide Treatment for IgG4-RD July 1, 2018 December 31, 2020
NCT01934764 Unknown status Identification of Correlations Between Reaction to Biotine and Autoimmune Diseases September 2013
NCT01665196 Unknown status Early Phase 1 18F-FDG PET/CT for IgG4-Related Disease September 2012 December 2017
NCT02458196 Unknown status Phase 2 Study of Treatment Response on IgG4 Related Disease (IgG4RD) April 2015 June 2018
NCT02948855 Withdrawn Regulation of LncRNA For Breg in Patients With Thymoma and Autoimmune Diseases October 2016 May 2018
Disase is a (Disease Ontology)
DOID:2914
Cross Reference ID (Disease Ontology)
ICD9CM:720
Cross Reference ID (Disease Ontology)
MIM:109100
Cross Reference ID (Disease Ontology)
UMLS_CUI:C0003089
Exact Synonym (Disease Ontology)
autoimmune hypersensitivity disease
Exact Synonym (Disease Ontology)
hypersensitivity reaction type II disease